Finance

Beta
Lists
2487:HKG
Cutia Therapeutics
HK$3.28
-2.67%
(-0.090) 1D
Jun 12, 10:29:00 AM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2487...
Open
HK$3.37
High
HK$3.39
Low
HK$3.28
Mkt. cap
1.19B
Avg. vol.
210.11K
Volume
23.20K
52-wk high
HK$12.84
52-wk low
HK$3.05
EPS
-HK$1.19
Shares outstanding
364.73M
No. of employees
304
Open
HK$3.37
High
HK$3.39
Low
HK$3.28
Mkt. cap
1.19B
Avg. vol.
210.11K
Volume
23.20K
52-wk high
HK$12.84
52-wk low
HK$3.05
EPS
-HK$1.19
Shares outstanding
364.73M
No. of employees
304
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to 2487 in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for 2487 in the last 3 months.
Highest
Current HK$3.28
HK$7.45 (+127.13%)
Average
HK$7.45 (+127.13%)
Lowest
HK$7.45 (+127.13%)
News stories
From sources across the web
About Cutia Therapeutics
CEO-
Employees304
Founded2019
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
33.14M
33.14M
134.93M
134.93M
Cost of goods sold
17.11M
17.11M
53.07M
53.07M
Cost of revenue
17.11M
17.11M
53.07M
53.07M
Research and development expenses
39.44M
39.44M
34.89M
34.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
77.95M
77.95M
95.69M
95.69M
Operating expense
120.98M
120.98M
131.22M
131.22M
Total operating expenses
138.10M
138.10M
184.28M
184.28M
Operating income
-104.95M
-104.95M
-49.35M
-49.35M
Other non operating income
-15.18M
-15.18M
3.06M
3.06M
EBT including unusual items
-119.69M
-119.69M
-50.40M
-50.40M
EBT excluding unusual items
-121.40M
-121.40M
-48.62M
-48.62M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-119.69M
-119.69M
-50.40M
-50.40M
Net profit margin
-361.12%
-361.12%
-37.35%
-37.35%
Earnings per share
-
-
-
-
Interest and investment income
1.59M
1.59M
1.67M
1.67M
Interest expense
-2.48M
-2.48M
-2.38M
-2.38M
Net interest expenses
-882.00K
-882.00K
-707.50K
-707.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-96.85M
-96.85M
-42.12M
-42.12M
Gain or loss from assets sale
486.50K
486.50K
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more